Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
GLP-1 and GLP-1/GIP products currently licensed for weight loss in the UKSaxenda (liraglutide), Wegovy (semaglutide), and Mounjaro (tirzepatide)are licensed by the Medicines and Healthcare products Regulatory Agency for patients who (i) have obesity (body mass index [BMI] 30 kg/m 2 ) or (ii) have a BMI in the overweight range (BMI 27 kg/m 2 ) plus weight-related comorbidities, such as cardiovascular disease [12]
With that coverage, Ros $149 membership plus a $25 to $50 co-pay beats MEDVis $299 cash rate
June 20, 2024
Su about your goals and the symptoms youd like to alleviate
Storage (after reconstitution): 28C
The platform's medical network includes physicians, nurse practitioners, and physician assistants licensed in patients' states of residence
US$ 21.74
US$ 20.64
US$ 26.30
US$ 21.45
US$ 28.09
US$ 27.30
US$ 23.14
